Taysha Gene Therapies (TSHA)
Advances TSHA-102, an AAV9 gene therapy in pivotal testing for Rett syndrome.
$5.28
After-hours close+0.13 (+2.45%)
At close$5.16(+2.28%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 42 days
EPS estimate
−$0.14
Revenue estimate
$755.6K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.07−$0.08−$0.09−$0.09−$0.08−$0.12−$0.13Pending
Estimate−$0.08−$0.08−$0.07−$0.09−$0.11−$0.10−$0.11−$0.14
Surprise+12.5%0.0%−28.6%0.0%+27.3%−20.0%−14.8%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$2.0M$2.3M$2.0M—$5.5M—$0Pending
Estimate$2.1M$1.1M$1.7M$1.9M$2.2M$755.6K$680.0K$755.6K
Surprise−1.5%+112.3%+14.9%—+144.5%—−100.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.13 | — | — |
| Sep 2027 | −$0.15 | — | — |
| Jun 2027 | −$0.14 | — | — |
| Mar 2027 | −$0.14 | — | — |
| Dec 2026 | −$0.13 | — | — |
| Nov 2026 | −$0.14 | — | — |
| Aug 2026 | −$0.11 | −$0.13 | −14.8% |
| May 2026 | −$0.10 | −$0.12 | −20.0% |
| Mar 2026 | −$0.11 | −$0.08 | +27.3% |
| Nov 2025 | −$0.09 | −$0.09 | 0.0% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Jun 2020 | |||
| Sep 2020 | |||
| Dec 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.13 | — | — | $20.0M | — | — | — |
| Sep 2027 | −$0.15 | — | — | $960.0K | — | — | — |
| Jun 2027 | −$0.14 | — | — | $800.0K | — | — | — |
| Mar 2027 | −$0.14 | — | — | $800.0K | — | — | — |
| Dec 2026 | −$0.13 | — | — | $1.6M | — | — | — |
| Nov 3, 2026 | −$0.14 | — | — | $755.6K | — | — | — |
| Aug 11, 2026 | −$0.11 | −$0.13 | −14.8% | $680.0K | $0 | −100.0% | −4.0% |
| May 6, 2026 | −$0.10 | −$0.12 | −20.0% | $755.6K | — | — | +0.6% |
| Mar 19, 2026 | −$0.11 | −$0.08 | +27.3% | $2.2M | $5.5M | +144.5% | +2.5% |
| Nov 4, 2025 | −$0.09 | −$0.09 | 0.0% | $1.9M | — | — | −4.3% |
| Aug 12, 2025 | |||||||
| May 15, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 19, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 28, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 11, 2021 | |||||||
| Mar 3, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Sep 25, 2020 | |||||||
| Dec 31, 2019 |